References

 

  1. American Hospital Formulary Service. Drug Information. Bethesda, MD: ASHP, 2008
  2. DiPiro JT, Ownby DR. Allergic and Pseudoallergic Drug Reactions. In: Dipiro JT,Talbert RL, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 6th ed. New York: McGraw-Hill; 2005: 1605-1606.
  3. Chyka PA. Clinical Toxicology. In: Dipiro JT,Talbert RL, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 6th ed. New York: McGraw-Hill; 2005: 125-148.
  4. Hirsh J, Guyatt G, et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):71S-109S.
  5. CathFlo Package Insert
  6. Antizol package Insert
  7. Argatroban Package Insert
  8. Verme-Gibboney CN, Hursting MJ. Argatroban dosing in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2003 Jul-Aug;37(7-8)970-5.
  9. Ramsay MAE, Savege TM, Simpson BRJ & Goodwin R. Controlled sedation with alpaxalone-alphadolone. British Medical Journal 1974; 2: 656 - 659.
  10. Trissel LA. Handbook on Injectable Drugs. 14th ed. Bethesda, MD: ASHP, 2006
  11. Corlopam Package Insert
  12. http://www.ashp.org/mngrphs/ahfs/a382557.htm
  13. Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999 Mar;84(3):838-43.
  14. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 14th ed. Hudson, OH:  Lexi-Comp
  15. Job, ML, Page RL. Digoxin (AHFS 24:04). In: Murphy, JE. Clinical Pharmacokinetics. 4th ed. Bethesda, MD: ASHP, 2007; 139-152
  16. Nolan PE, Trujillo TC. Lidocaine (AHFS 24:04.04). In: Murphy, JE. Clinical Pharmacokinetics. 4th ed. Bethesda, MD: ASHP, 2007; 189-207
  17. Natrecor Package Insert
  18. Precedex Package Insert
  19. Bracken MB, Shepard MJ, et all. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.J Neurosurg. 1998 Nov;89(5):699-706.
  20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE.APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct;13(10):818-29.
  21. Heinz P, Geelhoed GC, Wee C, Pascoe EM. Is atropine needed with ketamine sedation A prospective, randomised, double blind study. Emerg Med J. 2006 Mar;23(3)206-9.
  22. Rosenberg CA. GI cocktail. Ann Emerg Med. 1996 Jul;28(1):104-5.
  23. Szumita PM, Enfanto CM, Greenwood B, Wechsler ME. Vasopressin for vasopressor-dependent septic shock. Am J Health Syst Pharm. 2005 Sep 15;62(18):1931-6.